[#item_full_content] “Increased acceptance and understanding could drive greater consumer demand and foster more mainstream integration of hemp-derived products into appropriate regulated frameworks.” By Shawn Hauser, Vicente LLP The Drug Enforcement Administration’s (DEA) pending reclassification of marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA) marks a historic and long-overdue milestone in U.S. 
Read More
